Inherent variability of cancer-specific aneuploidy generates metastases

Abstract

BackgroundThe genetic basis of metastasis is still unclear because metastases carry individual karyotypes and phenotypes, rather than consistent mutations, and are rare compared to conventional mutation. There is however correlative evidence that metastasis depends on cancer-specific aneuploidy, and that metastases are karyotypically related to parental cancers. Accordingly we propose that metastasis is a speciation event. This theory holds that cancer-specific aneuploidy varies the clonal karyotypes of cancers automatically by unbalancing thousands of genes, and that rare variants form new autonomous subspecies with metastatic or other non-parental phenotypes like drug-resistance – similar to conventional subspeciation.ResultsTo test this theory, we analyzed the karyotypic and morphological relationships between seven cancers and corresponding metastases. We found (1) that the cellular phenotypes of metastases were closely related to those of parental cancers, (2) that metastases shared 29 to 96% of their clonal karyotypic elements or aneusomies with the clonal karyotypes of parental cancers and (3) that, unexpectedly, the karyotypic complexity of metastases was very similar to that of the parental cancer. This suggests that metastases derive cancer-specific autonomy by conserving the overall complexity of the parental karyotype. We deduced from these results that cancers cause metastases by karyotypic variations and selection for rare metastatic subspecies. Further we asked whether metastases with multiple metastasis-specific aneusomies are assembled in one or multiple, sequential steps. Since (1) no stable karyotypic intermediates of metastases were observed in cancers here and previously by others, and (2) the karyotypic complexities of cancers are conserved in metastases, we concluded that metastases are generated from cancers in one step – like subspecies in conventional speciation.ConclusionsWe conclude that the risk of cancers to metastasize is proportional to the degree of cancer-specific aneuploidy, because aneuploidy catalyzes the generation of subspecies, including metastases, at aneuploidy-dependent rates. Since speciation by random chromosomal rearrangements and selection is unpredictable, the theory that metastases are karyotypic subspecies of cancers also explains Foulds’ rules, which hold that the origins of metastases are “abrupt” and that their phenotypes are “unpredictable.”

Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives (Review)

“…Increasing evidence has indicated the complexity of cancer, which cannot be explained by somatic mutation theory. To address this complexity, additional ad hoc explanations have been postulated, and carcinogenesis is thought to represent a problem of tissue organization on the basis of tissue organization field theory (101)(102)(103). According to recent studies, chromosomal aberration-mediated genome evolution is responsible for all major transitions in cancer evolution, including phenotypic plasticity, metastasis and drug resistance (104,105).…”

The potential role of leptin in tumor invasion and metastasis

“…The progression model proposes the development of metastatic subpopulations or clone of mutated cells with metastatic potential within the primary tumor. It is known that tumor aneuploidy (chromosome number variation) and genetic heterogeneity/diversity can influence the disease behavior including metastatic capability [190–192]. Apart from genetic changes, epigenetic alterations such as DNA methylation and histone modifications could play a significant role in metastasis [193,194].…”

A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis

“…experimental procedures cell culture. IGR-39/IGR-37 (generous gifts from Prof. Peter H. Duesberg, with BRAF V600E and P53 C229fs ) 40 , WM-793/1205Lu (The Wistar Institute, with BRAF V600E , P53 WT and CDK4 K22Q ) cells were cultured in Dulbecco's modified eagle medium (DMEM). WM-115/WM-266-4 cells (ATCC, with BRAF V600D and P53 WT ) were cultured in Eagle's minimum essential medium (EMEM).…”